Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • Cytek Biosciences' Change in Inventory rose 16248.59% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 12773.99%. This contributed to the annual value of -$14.8 million for FY2024, which is 24426.04% down from last year.
  • According to the latest figures from Q3 2025, Cytek Biosciences' Change in Inventory is $2.2 million, which was up 16248.59% from $3.6 million recorded in Q2 2025.
  • Over the past 5 years, Cytek Biosciences' Change in Inventory peaked at $8.4 million during Q2 2022, and registered a low of -$6.3 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Inventory was $1.5 million (2025), whereas its average is $682894.7.
  • As far as peak fluctuations go, Cytek Biosciences' Change in Inventory soared by 314384.62% in 2022, and later crashed by 28834.75% in 2024.
  • Quarter analysis of 5 years shows Cytek Biosciences' Change in Inventory stood at $2.2 million in 2021, then tumbled by 184.48% to -$1.9 million in 2022, then plummeted by 236.15% to -$6.3 million in 2023, then surged by 68.42% to -$2.0 million in 2024, then surged by 211.1% to $2.2 million in 2025.
  • Its Change in Inventory stands at $2.2 million for Q3 2025, versus $3.6 million for Q2 2025 and $1.5 million for Q1 2025.